Communications of the ACM
Artificial Pancreas Developed at UVA Improves Blood Sugar Control for Kids Ages 2-6, Study Finds
The Control-IQ artificial pancreas system has an insulin pump that uses advanced control algorithms based on the person’s glucose-monitoring information to adjust the insulin dose as needed.
Credit: Tandem Diabetes Care
University of Virginia (UVA) researchers found that the Control-IQ diabetes management system improved blood sugar control in 2- to 6-year-olds with type 1 diabetes.
The device features an artificial pancreas equipped with an insulin pump that uses advanced control algorithms based on the person’s glucose-monitoring information to adjust the insulin dose as needed.
The researchers found that the 68 participants who used the Control-IQ system were in their target blood sugar range about three more hours per day than the 34 children in the control group.
Those with the artificial pancreas saw time spent in the target blood glucose range exceed that of the control group by around 12% overall, and by 18% during overnight hours.
From UVA Health Newsroom
View Full Article
Abstracts Copyright © 2023 SmithBucklin, Washington, D.C., USA
No entries found